How and Why Medical Affairs Can Support Diversity in Clinical Trials
In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the importance of patient-centric approaches. The speakers delve into the strategic roles of MSLs in education and the historical context of diversity in clinical trials. They provide actionable strategies for field medical teams to enhance trial diversity and emphasize the significance of cultural awareness and allyship. The episode concludes with reflections and a call to action for promoting diversity in medical settings.
Christina Wright, Brad Atkinson and Brian Wilson discuss the important role Medical Affairs/MSLs can play in supporting diversity in clinical trials
The group discusses…
👉 Why does medical affairs need to be involved in diversity clinical trial initiatives?
👉 How can field medical get comfortable with the D and I conversation?
👉 What resources can be helpful
👉 3 Pillars of “Allyship”
👉 Why insights are currency
